-
1
-
-
0032617868
-
Epidemiology of Parkinson's disease
-
Tanner CM, Ben-Shlomo Y. Epidemiology of Parkinson's disease. Adv Neurol 1999;80:153-9
-
(1999)
Adv Neurol
, vol.80
, pp. 153-159
-
-
Tanner, C.M.1
Ben-Shlomo, Y.2
-
2
-
-
7444234716
-
Economic evidence in Parkinson's disease: A review
-
Lindgren P. Economic evidence in Parkinson's disease: a review. Eur J Health Econ 2004;5 Suppl 1:S63-6
-
(2004)
Eur J Health Econ
, vol.5
, Issue.1 SUPPL.
-
-
Lindgren, P.1
-
5
-
-
0036091142
-
Occupational and environmental risk factors for Parkinson's disease
-
Lai BC, Marion SA, Teschke K, Tsui JK. Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Relat Disord 2002;8 5:297-309
-
(2002)
Parkinsonism Relat Disord
, vol.8
, Issue.5
, pp. 297-309
-
-
Lai, B.C.1
Marion, S.A.2
Teschke, K.3
Tsui, J.K.4
-
6
-
-
0042521076
-
The environment and Parkinson's disease: Is the nigrostriatal system preferentially targeted by neurotoxins?
-
Di Monte DA. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2003;2 9:531-8
-
(2003)
Lancet Neurol
, vol.2
, Issue.9
, pp. 531-538
-
-
Di Monte, D.A.1
-
7
-
-
0033695441
-
Levodopa motor complications in Parkinson's disease
-
Obeso JA, Olanow CW, Nutt JG. Levodopa motor complications in Parkinson's disease. Trends Neurosci 2000;23 10 Suppl:S2-7
-
(2000)
Trends Neurosci
, vol.23
, Issue.10 SUPPL.
-
-
Obeso, J.A.1
Olanow, C.W.2
Nutt, J.G.3
-
8
-
-
0031933258
-
An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
-
American Academy of Neurology
-
Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology. Neurology 1998;50 3 Suppl 3:S1-57
-
(1998)
Neurology
, vol.50
, Issue.3 SUPPL. 3
-
-
Olanow, C.W.1
Koller, W.C.2
-
9
-
-
0031439442
-
Parkinson's disease: Clinical features
-
Quinn NP. Parkinson's disease: clinical features. Baillieres Clin Neurol 1997;6 1:1-13
-
(1997)
Baillieres Clin Neurol
, vol.6
, Issue.1
, pp. 1-13
-
-
Quinn, N.P.1
-
10
-
-
7944228088
-
Cognitive and behavioral dysfunction in Parkinson's disease: Neurochemical and clinicopathological contributions
-
Zgaljardic DJ, Foldi NS, Borod JC. Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions. J Neural Transm 2004;111 10-1:1287-301
-
(2004)
J Neural Transm
, vol.111
, Issue.10-11
, pp. 1287-1301
-
-
Zgaljardic, D.J.1
Foldi, N.S.2
Borod, J.C.3
-
11
-
-
0032937059
-
Diagnostic criteria for Parkinson disease
-
Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56 1:33-9
-
(1999)
Arch Neurol
, vol.56
, Issue.1
, pp. 33-39
-
-
Gelb, D.J.1
Oliver, E.2
Gilman, S.3
-
12
-
-
0032916601
-
Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study
-
Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999;56 5:595-601
-
(1999)
Arch Neurol
, vol.56
, Issue.5
, pp. 595-601
-
-
Aarsland, D.1
Larsen, J.P.2
Cummins, J.L.3
Laake, K.4
-
13
-
-
5644244328
-
Depression and Parkinson's disease
-
Lemke MR, Fuchs G, Gemende I, Herting B, Oehlwein C, Reichmann H, et al. Depression and Parkinson's disease. J Neurol 2004;251 Suppl 6:VI/24-7
-
(2004)
J Neurol
, vol.251
, Issue.6 SUPPL.
-
-
Lemke, M.R.1
Fuchs, G.2
Gemende, I.3
Herting, B.4
Oehlwein, C.5
Reichmann, H.6
-
14
-
-
3442876461
-
Psychiatric aspects of Parkinson's disease - An update
-
Schrag A. Psychiatric aspects of Parkinson's disease - an update. J Neurol 2004;251 7:795-804
-
(2004)
J Neurol
, vol.251
, Issue.7
, pp. 795-804
-
-
Schrag, A.1
-
16
-
-
0001509014
-
Paralisis Agitans: I. Pathologisches anatomie
-
Berlin Heidelberg New York: Springer
-
Lewy F. Paralisis Agitans: I. Pathologisches anatomie. In: Handbuch der neurologie. Berlin Heidelberg New York: Springer; 1912. p. 920-33
-
(1912)
Handbuch der Neurologie
, pp. 920-933
-
-
Lewy, F.1
-
18
-
-
0000022434
-
Occurrence and distribution of catechol amines in brain
-
Bertler A, Rosengren E. Occurrence and distribution of catechol amines in brain. Acta Physiol Scand 1959;47:350-61
-
(1959)
Acta Physiol Scand
, vol.47
, pp. 350-361
-
-
Bertler, A.1
Rosengren, E.2
-
19
-
-
34250928307
-
Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrangungen des extrapyramidalen Systems
-
Ehinger H, Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrangungen des extrapyramidalen Systems. Klin Wochenschr 1960;38:1236-9
-
(1960)
Klin Wochenschr
, vol.38
, pp. 1236-1239
-
-
Ehinger, H.1
Hornykiewicz, O.2
-
20
-
-
0000486903
-
Catecholaminergic brain stem regulatory systems
-
Baltimore: Waverly Press
-
Bjorklund A, Lindvall O. Catecholaminergic brain stem regulatory systems. In: Handbook of physiology. Baltimore: Waverly Press; 1986. p. 155-235
-
(1986)
Handbook of Physiology
, pp. 155-235
-
-
Bjorklund, A.1
Lindvall, O.2
-
21
-
-
0027342284
-
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
-
Agid Y, Ruberg M, Javoy-Agid F, Hirsch E, Raisman-Vozari R, Vyas S, et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease? Adv Neurol 1993;60:148-64
-
(1993)
Adv Neurol
, vol.60
, pp. 148-164
-
-
Agid, Y.1
Ruberg, M.2
Javoy-Agid, F.3
Hirsch, E.4
Raisman-Vozari, R.5
Vyas, S.6
-
22
-
-
0023740954
-
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
-
Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988;334 6180:345-8
-
(1988)
Nature
, vol.334
, Issue.6180
, pp. 345-348
-
-
Hirsch, E.1
Graybiel, A.M.2
Agid, Y.A.3
-
23
-
-
0000056069
-
Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus
-
Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476
-
(1938)
J Psychol Neurol
, vol.48
, pp. 387-476
-
-
Hassler, R.1
-
24
-
-
0025954066
-
Ageing and Parkinson's disease: Substantia nigra regional selectivity
-
Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114 Pt 5:2283-301
-
(1991)
Brain
, vol.114
, Issue.5 PART
, pp. 2283-2301
-
-
Fearnley, J.M.1
Lees, A.J.2
-
25
-
-
51249181873
-
Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's disease
-
Nyberg P, Nordberg A, Wester P, Winblad B. Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's disease. Neurochem Pathol 1983;1:193-202
-
(1983)
Neurochem Pathol
, vol.1
, pp. 193-202
-
-
Nyberg, P.1
Nordberg, A.2
Wester, P.3
Winblad, B.4
-
26
-
-
0023874410
-
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications
-
Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318 14:876-80
-
(1988)
N Engl J Med
, vol.318
, Issue.14
, pp. 876-880
-
-
Kish, S.J.1
Shannak, K.2
Hornykiewicz, O.3
-
27
-
-
0032816549
-
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
-
Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122 Pt 8:1437-48
-
(1999)
Brain
, vol.122
, Issue.8 PART
, pp. 1437-1448
-
-
Damier, P.1
Hirsch, E.C.2
Agid, Y.3
Graybiel, A.M.4
-
28
-
-
0014208039
-
Aromatic amino acids and modification of parkinsonism
-
Cotzias J, Van Woert M, Scheffer L. Aromatic amino acids and modification of parkinsonism. N Engl J Med 1967;276:374-9
-
(1967)
N Engl J Med
, vol.276
, pp. 374-379
-
-
Cotzias, J.1
Van Woert, M.2
Scheffer, L.3
-
29
-
-
0024347984
-
Pathogenesis of dyskinesias in Parkinson's disease
-
Mouradian MM, Heuser IJ, Baronti F, Fabbrini G, Juncos JL, Chase TN. Pathogenesis of dyskinesias in Parkinson's disease. Ann Neurol 1989;25 5:523-6
-
(1989)
Ann Neurol
, vol.25
, Issue.5
, pp. 523-526
-
-
Mouradian, M.M.1
Heuser, I.J.2
Baronti, F.3
Fabbrini, G.4
Juncos, J.L.5
Chase, T.N.6
-
30
-
-
0027725064
-
Motor response complications and the function of striatal efferent systems
-
Chase TN, Mouradian MM, Engber TM. Motor response complications and the function of striatal efferent systems. Neurology 1993;43 12 Suppl 6:S23-7
-
(1993)
Neurology
, vol.43
, Issue.12 SUPPL. 6
-
-
Chase, T.N.1
Mouradian, M.M.2
Engber, T.M.3
-
31
-
-
0033696872
-
Continuous dopamine-receptor stimulation in advanced Parkinson's disease
-
Nutt JG, Obeso JA, Stocchi F. Continuous dopamine-receptor stimulation in advanced Parkinson's disease. Trends Neurosci 2000;23 10 Suppl:S109-15
-
(2000)
Trends Neurosci
, vol.23
, Issue.10 SUPPL.
-
-
Nutt, J.G.1
Obeso, J.A.2
Stocchi, F.3
-
32
-
-
0034682308
-
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
-
056 Study Group
-
Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000;342 20:1484-91
-
(2000)
N Engl J Med
, vol.342
, Issue.20
, pp. 1484-1491
-
-
Rascol, O.1
Brooks, D.J.2
Korczyn, A.D.3
De Deyn, P.P.4
Clarke, C.E.5
Lang, A.E.6
-
33
-
-
0036723589
-
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
-
Stocchi F, Ruggieri S, Vacca L, Olanow CW. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease. Brain 2002;125 Pt 9:2058-66
-
(2002)
Brain
, vol.125
, Issue.9 PART
, pp. 2058-2066
-
-
Stocchi, F.1
Ruggieri, S.2
Vacca, L.3
Olanow, C.W.4
-
34
-
-
0034050670
-
The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease
-
Rascol O. The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease. J Neurol 2000;247 Suppl 2:II51-7
-
(2000)
J Neurol
, vol.247
, Issue.2 SUPPL.
-
-
Rascol, O.1
-
35
-
-
0035353741
-
Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study
-
Del Dotto P, Pavese N, Gambaccini G, Bernardini S, Metman LV, Chase TN, et al. Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. Mov Disord 2001;16 3:515-20
-
(2001)
Mov Disord
, vol.16
, Issue.3
, pp. 515-520
-
-
Del Dotto, P.1
Pavese, N.2
Gambaccini, G.3
Bernardini, S.4
Metman, L.V.5
Chase, T.N.6
-
36
-
-
0025058215
-
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
-
Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247 4942:574-7
-
(1990)
Science
, vol.247
, Issue.4942
, pp. 574-577
-
-
Lindvall, O.1
Brundin, P.2
Widner, H.3
Rehncrona, S.4
Gustavii, B.5
Frackowiak, R.6
-
37
-
-
21844473567
-
Cell therapy in Parkinson's disease
-
Lindvall O, Bjorklund A. Cell therapy in Parkinson's disease. Neurorx 2004;1 4:382-93
-
(2004)
Neurorx
, vol.1
, Issue.4
, pp. 382-393
-
-
Lindvall, O.1
Bjorklund, A.2
-
38
-
-
13144259693
-
Cell transplantation in Parkinson's disease: How can we make it work?
-
Winkler C, Kirik D, Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 2005;28 2:86-92
-
(2005)
Trends Neurosci
, vol.28
, Issue.2
, pp. 86-92
-
-
Winkler, C.1
Kirik, D.2
Bjorklund, A.3
-
39
-
-
0033168820
-
Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: An argument for neurotrophic supplementation
-
Collier TJ, Sortwell CE, Daley BF. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J Neurosci 1999;19 13:5563-73
-
(1999)
J Neurosci
, vol.19
, Issue.13
, pp. 5563-5573
-
-
Collier, T.J.1
Sortwell, C.E.2
Daley, B.F.3
-
40
-
-
0035871386
-
Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration
-
Kirik D, Winkler C, Bjorklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci 2001;21 8:2889-96
-
(2001)
J Neurosci
, vol.21
, Issue.8
, pp. 2889-2896
-
-
Kirik, D.1
Winkler, C.2
Bjorklund, A.3
-
41
-
-
0035826089
-
Transplantation of embryonic dopamine neurons for severe Parkinson's disease
-
Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344 10:710-9
-
(2001)
N Engl J Med
, vol.344
, Issue.10
, pp. 710-719
-
-
Freed, C.R.1
Greene, P.E.2
Breeze, R.E.3
Tsai, W.Y.4
DuMouchel, W.5
Kao, R.6
-
42
-
-
0042837887
-
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
-
Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54 3:403-14
-
(2003)
Ann Neurol
, vol.54
, Issue.3
, pp. 403-414
-
-
Olanow, C.W.1
Goetz, C.G.2
Kordower, J.H.3
Stoessl, A.J.4
Sossi, V.5
Brin, M.F.6
-
43
-
-
0021028244
-
A polymorphic DNA marker genetically linked to Huntington's disease
-
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306 5940:234-8
-
(1983)
Nature
, vol.306
, Issue.5940
, pp. 234-238
-
-
Gusella, J.F.1
Wexler, N.S.2
Conneally, P.M.3
Naylor, S.L.4
Anderson, M.A.5
Tanzi, R.E.6
-
44
-
-
0027480960
-
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
-
The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72 6:971-83
-
(1993)
Cell
, vol.72
, Issue.6
, pp. 971-983
-
-
-
45
-
-
0032190391
-
The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human
-
Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J Neurosci 1998;18 19:7674-86
-
(1998)
J Neurosci
, vol.18
, Issue.19
, pp. 7674-7686
-
-
Gutekunst, C.A.1
Li, S.H.2
Yi, H.3
Ferrante, R.J.4
Li, X.J.5
Hersch, S.M.6
-
46
-
-
0029664992
-
Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH
-
Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD, et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996;2 3:347-50
-
(1996)
Nat Med
, vol.2
, Issue.3
, pp. 347-350
-
-
Burke, J.R.1
Enghild, J.J.2
Martin, M.E.3
Jou, Y.S.4
Myers, R.M.5
Roses, A.D.6
-
47
-
-
0030001072
-
Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin
-
U S A
-
Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, et al. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci U S A 1996;93 10:5037-42
-
(1996)
Proc Natl Acad Sci
, vol.93
, Issue.10
, pp. 5037-5042
-
-
Bao, J.1
Sharp, A.H.2
Wagster, M.V.3
Becher, M.4
Schilling, G.5
Ross, C.A.6
-
48
-
-
9444239187
-
Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme
-
Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, et al. Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem 1996;271 32:19385-94
-
(1996)
J Biol Chem
, vol.271
, Issue.32
, pp. 19385-19394
-
-
Kalchman, M.A.1
Graham, R.K.2
Xia, G.3
Koide, H.B.4
Hodgson, J.G.5
Graham, K.C.6
-
49
-
-
0030986659
-
HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain
-
Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat Genet 1997;16 1:44-53
-
(1997)
Nat Genet
, vol.16
, Issue.1
, pp. 44-53
-
-
Kalchman, M.A.1
Koide, H.B.2
McCutcheon, K.3
Graham, R.K.4
Nichol, K.5
Nishiyama, K.6
-
50
-
-
0030919567
-
Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
-
Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997;41 5:646-53
-
(1997)
Ann Neurol
, vol.41
, Issue.5
, pp. 646-653
-
-
Browne, S.E.1
Bowling, A.C.2
MacGarvey, U.3
Baik, M.J.4
Berger, S.C.5
Muqit, M.M.6
-
51
-
-
0031044805
-
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
-
Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 1997;41 2:160-5
-
(1997)
Ann Neurol
, vol.41
, Issue.2
, pp. 160-165
-
-
Koroshetz, W.J.1
Jenkins, B.G.2
Rosen, B.R.3
Beal, M.F.4
-
53
-
-
0030787762
-
Toward understanding the molecular pathology of Huntington's disease
-
Wellington CL, Brinkman RR, O'Kusky JR, Hayden MR. Toward understanding the molecular pathology of Huntington's disease. Brain Pathol 1997;7 3:979-1002
-
(1997)
Brain Pathol
, vol.7
, Issue.3
, pp. 979-1002
-
-
Wellington, C.L.1
Brinkman, R.R.2
O'Kusky, J.R.3
Hayden, M.R.4
-
54
-
-
0026928944
-
New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease
-
Kremer B, Weber B, Hayden MR. New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease. Brain Pathol 1992;2 4:321-35
-
(1992)
Brain Pathol
, vol.2
, Issue.4
, pp. 321-335
-
-
Kremer, B.1
Weber, B.2
Hayden, M.R.3
-
55
-
-
0023880409
-
The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement
-
Thompson PD, Berardelli A, Rothwell JC, Day BL, Dick JP, Benecke R, et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 1988;111 Pt 2:223-44
-
(1988)
Brain
, vol.111
, Issue.2 PART
, pp. 223-244
-
-
Thompson, P.D.1
Berardelli, A.2
Rothwell, J.C.3
Day, B.L.4
Dick, J.P.5
Benecke, R.6
-
56
-
-
0024242568
-
Language functions in Huntington's disease
-
Podoll K, Caspary P, Lange HW, Noth J. Language functions in Huntington's disease. Brain 1988;111 Pt 6:1475-503
-
(1988)
Brain
, vol.111
, Issue.6 PART
, pp. 1475-1503
-
-
Podoll, K.1
Caspary, P.2
Lange, H.W.3
Noth, J.4
-
57
-
-
0022395922
-
Neuropathological classification of Huntington's disease
-
Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44 6:559-77
-
(1985)
J Neuropathol Exp Neurol
, vol.44
, Issue.6
, pp. 559-577
-
-
Vonsattel, J.P.1
Myers, R.H.2
Stevens, T.J.3
Ferrante, R.J.4
Bird, E.D.5
Richardson Jr., E.P.6
-
58
-
-
0023865274
-
Clinical and neuropathologic assessment of severity in Huntington's disease
-
Myers RH, Vonsattel JP, Stevens TJ, Cupples LA, Richardson EP, Martin JB, et al. Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 1988;38 3:341-7
-
(1988)
Neurology
, vol.38
, Issue.3
, pp. 341-347
-
-
Myers, R.H.1
Vonsattel, J.P.2
Stevens, T.J.3
Cupples, L.A.4
Richardson, E.P.5
Martin, J.B.6
-
60
-
-
0022343684
-
Selective sparing of a class of striatal neurons in Huntington's disease
-
Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr., Bird ED, Martin JB. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985;230 4725:561-3
-
(1985)
Science
, vol.230
, Issue.4725
, pp. 561-563
-
-
Ferrante, R.J.1
Kowall, N.W.2
Beal, M.F.3
Richardson Jr., E.P.4
Bird, E.D.5
Martin, J.B.6
-
61
-
-
0019524259
-
Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease
-
Buck SH, Burks TF, Brown MR, Yamamura HI. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease. Brain Res 1981;209 2:464-9
-
(1981)
Brain Res
, vol.209
, Issue.2
, pp. 464-469
-
-
Buck, S.H.1
Burks, T.F.2
Brown, M.R.3
Yamamura, H.I.4
-
62
-
-
0029586383
-
Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients
-
Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 1995;38 6:852-61
-
(1995)
Ann Neurol
, vol.38
, Issue.6
, pp. 852-861
-
-
Richfield, E.K.1
Maguire-Zeiss, K.A.2
Vonkeman, H.E.3
Voorn, P.4
-
63
-
-
0027380104
-
Neurochemical substrates of rigidity and chorea in Huntington's disease
-
Storey E, Beal MF. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain 1993;116 Pt 5:1201-22
-
(1993)
Brain
, vol.116
, Issue.5 PART
, pp. 1201-1222
-
-
Storey, E.1
Beal, M.F.2
-
64
-
-
0026320986
-
Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: A combined study using the section-Golgi method and calbindin D28k immunocytochemistry
-
Ferrante RJ, Kowall NW, Richardson EP Jr. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 1991;11 12:3877-87
-
(1991)
J Neurosci
, vol.11
, Issue.12
, pp. 3877-3887
-
-
Ferrante, R.J.1
Kowall, N.W.2
Richardson Jr., E.P.3
-
65
-
-
0028799793
-
Early loss of neostriatal striosome neurons in Huntington's disease
-
Hedreen JC, Folstein SE. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995;54 1:105-20
-
(1995)
J Neuropathol Exp Neurol
, vol.54
, Issue.1
, pp. 105-120
-
-
Hedreen, J.C.1
Folstein, S.E.2
-
66
-
-
0023950143
-
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease
-
Beal MF, Mazurek MF, Ellison DW, Swartz KJ, McGarvey U, Bird ED, et al. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease. Ann Neurol 1988;23 6:562-9
-
(1988)
Ann Neurol
, vol.23
, Issue.6
, pp. 562-569
-
-
Beal, M.F.1
Mazurek, M.F.2
Ellison, D.W.3
Swartz, K.J.4
McGarvey, U.5
Bird, E.D.6
-
68
-
-
0025823405
-
Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues
-
U S A
-
Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A 1991;88 17:7797-801
-
(1991)
Proc Natl Acad Sci
, vol.88
, Issue.17
, pp. 7797-7801
-
-
Dawson, T.M.1
Bredt, D.S.2
Fotuhi, M.3
Hwang, P.M.4
Snyder, S.H.5
-
69
-
-
0026570890
-
Nitric oxide, a novel neuronal messenger
-
Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992;8 1:3-11
-
(1992)
Neuron
, vol.8
, Issue.1
, pp. 3-11
-
-
Bredt, D.S.1
Snyder, S.H.2
-
70
-
-
0027178135
-
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
-
Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13 6:2651-61
-
(1993)
J Neurosci
, vol.13
, Issue.6
, pp. 2651-2661
-
-
Dawson, V.L.1
Dawson, T.M.2
Bartley, D.A.3
Uhl, G.R.4
Snyder, S.H.5
-
71
-
-
0023080626
-
Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease
-
Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EP Jr. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 1987;46 1:12-27
-
(1987)
J Neuropathol Exp Neurol
, vol.46
, Issue.1
, pp. 12-27
-
-
Ferrante, R.J.1
Kowall, N.W.2
Beal, M.F.3
Martin, J.B.4
Bird, E.D.5
Richardson Jr., E.P.6
-
72
-
-
0018973928
-
Neurochemical alterations in Huntington's chorea: A study of post-mortem brain tissue
-
Spokes EG. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue. Brain 1980;103 1:179-210
-
(1980)
Brain
, vol.103
, Issue.1
, pp. 179-210
-
-
Spokes, E.G.1
-
73
-
-
0017288049
-
Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea
-
McGeer PL, McGeer EG. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 1976;26 1:65-76
-
(1976)
J Neurochem
, vol.26
, Issue.1
, pp. 65-76
-
-
McGeer, P.L.1
McGeer, E.G.2
-
74
-
-
0023269358
-
Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum
-
Kish SJ, Shannak K, Hornykiewicz O. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Ann Neurol 1987;22 3:386-9
-
(1987)
Ann Neurol
, vol.22
, Issue.3
, pp. 386-389
-
-
Kish, S.J.1
Shannak, K.2
Hornykiewicz, O.3
-
75
-
-
0030752709
-
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
-
DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277 5334:1990-3
-
(1997)
Science
, vol.277
, Issue.5334
, pp. 1990-1993
-
-
DiFiglia, M.1
Sapp, E.2
Chase, K.O.3
Davies, S.W.4
Bates, G.P.5
Vonsattel, J.P.6
-
76
-
-
0026609559
-
Alternative excitotoxic hypotheses
-
Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology 1992;42 4:733-8
-
(1992)
Neurology
, vol.42
, Issue.4
, pp. 733-738
-
-
Albin, R.L.1
Greenamyre, J.T.2
-
77
-
-
0023873665
-
Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia
-
Martin JJ, Van de Vyver FL, Scholte HR, Roodhooft AM, Ceuterick C, Martin L, et al. Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia. J Neurol Sci 1988;84 2-3:189-200
-
(1988)
J Neurol Sci
, vol.84
, Issue.2-3
, pp. 189-200
-
-
Martin, J.J.1
Van De Vyver, F.L.2
Scholte, H.R.3
Roodhooft, A.M.4
Ceuterick, C.5
Martin, L.6
-
78
-
-
0029159804
-
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
-
Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11 2:144-9
-
(1995)
Nat Genet
, vol.11
, Issue.2
, pp. 144-149
-
-
Bourgeron, T.1
Rustin, P.2
Chretien, D.3
Birch-Machin, M.4
Bourgeois, M.5
Viegas-Pequignot, E.6
-
79
-
-
0029440732
-
Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid)
-
He F, Zhang S, Qian F, Zhang C. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 1995;45 12:2178-83
-
(1995)
Neurology
, vol.45
, Issue.12
, pp. 2178-2183
-
-
He, F.1
Zhang, S.2
Qian, F.3
Zhang, C.4
-
80
-
-
0031887047
-
Safety of intrastriatal neurotransplantation for Huntington's disease patients
-
Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 1998;149 1:97-108
-
(1998)
Exp Neurol
, vol.149
, Issue.1
, pp. 97-108
-
-
Kopyov, O.V.1
Jacques, S.2
Lieberman, A.3
Duma, C.M.4
Eagle, K.S.5
-
81
-
-
0034627143
-
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation
-
Bachoud-Levi AC, Remy P, Nguyen JP, Brugieres P, Lefaucheur JP, Bourdet C, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000;356 9246:1975-9
-
(2000)
Lancet
, vol.356
, Issue.9246
, pp. 1975-1979
-
-
Bachoud-Levi, A.C.1
Remy, P.2
Nguyen, J.P.3
Brugieres, P.4
Lefaucheur, J.P.5
Bourdet, C.6
-
82
-
-
5644295321
-
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study
-
Bloch J, Bachoud-Levi AC, Deglon N, Lefaucheur JP, Winkel L, Palfi S, et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum Gene Ther 2004;15 10:968-75
-
(2004)
Hum Gene Ther
, vol.15
, Issue.10
, pp. 968-975
-
-
Bloch, J.1
Bachoud-Levi, A.C.2
Deglon, N.3
Lefaucheur, J.P.4
Winkel, L.5
Palfi, S.6
-
83
-
-
0017368491
-
14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
-
14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28 5:897-916
-
(1977)
J Neurochem
, vol.28
, Issue.5
, pp. 897-916
-
-
Sokoloff, L.1
Reivich, M.2
Kennedy, C.3
Des Rosiers, M.H.4
Patlak, C.S.5
Pettigrew, K.D.6
-
84
-
-
0025818553
-
Positron emission tomography studies of brain receptors
-
Maziere B, Maziere M. Positron emission tomography studies of brain receptors. Fundam Clin Pharmacol 1991;5 1:61-91
-
(1991)
Fundam Clin Pharmacol
, vol.5
, Issue.1
, pp. 61-91
-
-
Maziere, B.1
Maziere, M.2
-
85
-
-
0026773680
-
Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology
-
Stocklin G. Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology. Eur J Nucl Med 1992;19 7:527-51
-
(1992)
Eur J Nucl Med
, vol.19
, Issue.7
, pp. 527-551
-
-
Stocklin, G.1
-
86
-
-
5444262034
-
Update on PET radiopharmaceuticals: Life beyond fluorodeoxyglucose
-
Shiue CY, Welch MJ. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose. Radiol Clin North Am 2004;42 6:1033-53, viii
-
(2004)
Radiol Clin North Am
, vol.42
, Issue.6
, pp. 1033-1053
-
-
Shiue, C.Y.1
Welch, M.J.2
-
87
-
-
20844455452
-
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
-
Hamill TG, Krause S, Ryan C, Bonnefous C, Govek S, Seiders TJ, et al. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse 2005;56 4:205-16
-
(2005)
Synapse
, vol.56
, Issue.4
, pp. 205-216
-
-
Hamill, T.G.1
Krause, S.2
Ryan, C.3
Bonnefous, C.4
Govek, S.5
Seiders, T.J.6
-
88
-
-
0038727935
-
PET studies on the function of dopamine in health and Parkinson's disease
-
Brooks DJ. PET studies on the function of dopamine in health and Parkinson's disease. Ann N Y Acad Sci 2003;991:22-35
-
(2003)
Ann N Y Acad Sci
, vol.991
, pp. 22-35
-
-
Brooks, D.J.1
-
89
-
-
0033491121
-
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
-
Piccini P, Brooks DJ, Bjorklund A, Gunn RN, Grasby PM, Rimoldi O, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999;2 12:1137-40
-
(1999)
Nat Neurosci
, vol.2
, Issue.12
, pp. 1137-1140
-
-
Piccini, P.1
Brooks, D.J.2
Bjorklund, A.3
Gunn, R.N.4
Grasby, P.M.5
Rimoldi, O.6
-
90
-
-
0038249170
-
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
-
Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003;9 5:589-95
-
(2003)
Nat Med
, vol.9
, Issue.5
, pp. 589-595
-
-
Gill, S.S.1
Patel, N.K.2
Hotton, G.R.3
O'Sullivan, K.4
McCarter, R.5
Bunnage, M.6
-
91
-
-
0026557644
-
Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine
-
Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, et al. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 1992;49 2:144-8
-
(1992)
Arch Neurol
, vol.49
, Issue.2
, pp. 144-148
-
-
Rascol, O.1
Sabatini, U.2
Chollet, F.3
Celsis, P.4
Montastruc, J.L.5
Marc-Vergnes, J.P.6
-
92
-
-
0032554885
-
Evidence for striatal dopamine release during a video game
-
Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, et al. Evidence for striatal dopamine release during a video game. Nature 1998;393 6682:266-8
-
(1998)
Nature
, vol.393
, Issue.6682
, pp. 266-268
-
-
Koepp, M.J.1
Gunn, R.N.2
Lawrence, A.D.3
Cunningham, V.J.4
Dagher, A.5
Jones, T.6
-
93
-
-
10344236071
-
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias
-
de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 2004;127 Pt 12:2747-54
-
(2004)
Brain
, vol.127
, Issue.12 PART
, pp. 2747-2754
-
-
De La Fuente-Fernandez, R.1
Sossi, V.2
Huang, Z.3
Furtado, S.4
Lu, J.Q.5
Calne, D.B.6
-
94
-
-
0031467450
-
Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease
-
Antonini A, Leenders KL, Vontobel P, Maguire RP, Missimer J, Psylla M, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997;120 Pt 12:2187-95
-
(1997)
Brain
, vol.120
, Issue.12 PART
, pp. 2187-2195
-
-
Antonini, A.1
Leenders, K.L.2
Vontobel, P.3
Maguire, R.P.4
Missimer, J.5
Psylla, M.6
-
95
-
-
20444477480
-
Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system
-
Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128 Pt 6:1314-22
-
(2005)
Brain
, vol.128
, Issue.6 PART
, pp. 1314-1322
-
-
Remy, P.1
Doder, M.2
Lees, A.3
Turjanski, N.4
Brooks, D.5
-
97
-
-
0021187087
-
Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease
-
Garnett ES, Firnau G, Nahmias C, Carbotte R, Bartolucci G. Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease. J Neurol Sci 1984;65 2:231-7
-
(1984)
J Neurol Sci
, vol.65
, Issue.2
, pp. 231-237
-
-
Garnett, E.S.1
Firnau, G.2
Nahmias, C.3
Carbotte, R.4
Bartolucci, G.5
-
98
-
-
0027441163
-
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease
-
Kuwert T, Lange HW, Boecker H, Titz H, Herzog H, Aulich A, et al. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol 1993;241 1:31-6
-
(1993)
J Neurol
, vol.241
, Issue.1
, pp. 31-36
-
-
Kuwert, T.1
Lange, H.W.2
Boecker, H.3
Titz, H.4
Herzog, H.5
Aulich, A.6
-
99
-
-
0023147905
-
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease
-
Mazziotta JC, Phelps ME, Pahl JJ, Huang SC, Baxter LR, Riege WH, et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 1987;316 7:357-62
-
(1987)
N Engl J Med
, vol.316
, Issue.7
, pp. 357-362
-
-
Mazziotta, J.C.1
Phelps, M.E.2
Pahl, J.J.3
Huang, S.C.4
Baxter, L.R.5
Riege, W.H.6
-
100
-
-
8644231592
-
Neuroimaging trials of Parkinson's disease progression
-
Seibyl J, Jennings D, Tabamo R, Marek K. Neuroimaging trials of Parkinson's disease progression. J Neurol 2004;251 Suppl 7:vII9-13
-
(2004)
J Neurol
, vol.251
, Issue.7 SUPPL.
-
-
Seibyl, J.1
Jennings, D.2
Tabamo, R.3
Marek, K.4
-
101
-
-
0037785449
-
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
-
Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol 2003;54 1:93-101
-
(2003)
Ann Neurol
, vol.54
, Issue.1
, pp. 93-101
-
-
Whone, A.L.1
Watts, R.L.2
Stoessl, A.J.3
Davis, M.4
Reske, S.5
Nahmias, C.6
-
102
-
-
0028911848
-
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
-
Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995;332 17:1118-24
-
(1995)
N Engl J Med
, vol.332
, Issue.17
, pp. 1118-1124
-
-
Kordower, J.H.1
Freeman, T.B.2
Snow, B.J.3
Vingerhoets, F.J.4
Mufson, E.J.5
Sanberg, P.R.6
-
103
-
-
21944436225
-
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease
-
Mendez I, Sanchez-Pernaute R, Cooper O, Vinuela A, Ferrari D, Bjorklund L, et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005;128 Pt 7:1498-510
-
(2005)
Brain
, vol.128
, Issue.7 PART
, pp. 1498-1510
-
-
Mendez, I.1
Sanchez-Pernaute, R.2
Cooper, O.3
Vinuela, A.4
Ferrari, D.5
Bjorklund, L.6
-
104
-
-
0030834093
-
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
-
Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997;42 1:95-107
-
(1997)
Ann Neurol
, vol.42
, Issue.1
, pp. 95-107
-
-
Wenning, G.K.1
Odin, P.2
Morrish, P.3
Rehncrona, S.4
Widner, H.5
Brundin, P.6
-
105
-
-
7144254462
-
Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients
-
Levivier M, Dethy S, Rodesch F, Peschanski M, Vandesteene A, David P, et al. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact Funct Neurosurg 1997;69 1-4 Pt 2:99-111
-
(1997)
Stereotact Funct Neurosurg
, vol.69
, Issue.1-4 PART 2
, pp. 99-111
-
-
Levivier, M.1
Dethy, S.2
Rodesch, F.3
Peschanski, M.4
Vandesteene, A.5
David, P.6
-
106
-
-
0036830588
-
Dyskinesia after fetal cell transplantation for parkinsonism: A PET study
-
Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 2002;52 5:628-34
-
(2002)
Ann Neurol
, vol.52
, Issue.5
, pp. 628-634
-
-
Ma, Y.1
Feigin, A.2
Dhawan, V.3
Fukuda, M.4
Shi, Q.5
Greene, P.6
-
107
-
-
10744219751
-
Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
-
Cochen V, Ribeiro MJ, Nguyen JP, Gurruchaga JM, Villafane G, Loc'h C, et al. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov Disord 2003;18 8:928-32
-
(2003)
Mov Disord
, vol.18
, Issue.8
, pp. 928-932
-
-
Cochen, V.1
Ribeiro, M.J.2
Nguyen, J.P.3
Gurruchaga, J.M.4
Villafane, G.5
Loc'h, C.6
-
108
-
-
0033767269
-
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
-
Piccini P, Lindvall O, Bjorklund A, Brundin P, Hagell P, Ceravolo R, et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000;48 5:689-95
-
(2000)
Ann Neurol
, vol.48
, Issue.5
, pp. 689-695
-
-
Piccini, P.1
Lindvall, O.2
Bjorklund, A.3
Brundin, P.4
Hagell, P.5
Ceravolo, R.6
-
109
-
-
9144221004
-
Striatal neural grafting improves cortical metabolism in Huntington's disease patients
-
Gaura V, Bachoud-Levi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S, et al. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 2004;127 Pt 1:65-72
-
(2004)
Brain
, vol.127
, Issue.1 PART
, pp. 65-72
-
-
Gaura, V.1
Bachoud-Levi, A.C.2
Ribeiro, M.J.3
Nguyen, J.P.4
Frouin, V.5
Baudic, S.6
-
110
-
-
0345415042
-
In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing
-
Leergaard TB, Bjaalie JG, Devor A, Wald LL, Dale AM. In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing. NeuroImage 2003;20 3:1591-600
-
(2003)
NeuroImage
, vol.20
, Issue.3
, pp. 1591-1600
-
-
Leergaard, T.B.1
Bjaalie, J.G.2
Devor, A.3
Wald, L.L.4
Dale, A.M.5
-
111
-
-
0027450301
-
Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
-
Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13 3:981-9
-
(1993)
J Neurosci
, vol.13
, Issue.3
, pp. 981-989
-
-
Urenjak, J.1
Williams, S.R.2
Gadian, D.G.3
Noble, M.4
-
112
-
-
0036483610
-
What does fMRI tell us about neuronal activity?
-
Heeger DJ, Ress D. What does fMRI tell us about neuronal activity? Nat Rev Neurosci 2002;3 2:142-51
-
(2002)
Nat Rev Neurosci
, vol.3
, Issue.2
, pp. 142-151
-
-
Heeger, D.J.1
Ress, D.2
-
113
-
-
0025323825
-
Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system
-
Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS, Wendland MF, et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176 2:439-45
-
(1990)
Radiology
, vol.176
, Issue.2
, pp. 439-445
-
-
Moseley, M.E.1
Cohen, Y.2
Kucharczyk, J.3
Mintorovitch, J.4
Asgari, H.S.5
Wendland, M.F.6
-
114
-
-
0036868662
-
Fiber tracking: Principles and strategies - A technical review
-
Mori S, van Zijl PC. Fiber tracking: principles and strategies - a technical review. NMR Biomed 2002;15 7-8:468-80
-
(2002)
NMR Biomed
, vol.15
, Issue.7-8
, pp. 468-480
-
-
Mori, S.1
Van Zijl, P.C.2
-
117
-
-
0041589706
-
Parkinson's disease is associated with hippocampal atrophy
-
Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003;18 7:784-90
-
(2003)
Mov Disord
, vol.18
, Issue.7
, pp. 784-790
-
-
Camicioli, R.1
Moore, M.M.2
Kinney, A.3
Corbridge, E.4
Glassberg, K.5
Kaye, J.A.6
-
118
-
-
13444254133
-
Structural brain changes in Parkinson disease with dementia: A voxel-based morphometry study
-
Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti MJ, et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005;62 2:281-5
-
(2005)
Arch Neurol
, vol.62
, Issue.2
, pp. 281-285
-
-
Summerfield, C.1
Junque, C.2
Tolosa, E.3
Salgado-Pineda, P.4
Gomez-Anson, B.5
Marti, M.J.6
-
119
-
-
0036829477
-
Differentiating multiple system atrophy from Parkinson's disease: Contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging
-
Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002;73 5:517-23
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.73
, Issue.5
, pp. 517-523
-
-
Ghaemi, M.1
Hilker, R.2
Rudolf, J.3
Sobesky, J.4
Heiss, W.D.5
-
120
-
-
1842609777
-
Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease
-
Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. NeuroImage 2004;21 4:1443-51
-
(2004)
NeuroImage
, vol.21
, Issue.4
, pp. 1443-1451
-
-
Schocke, M.F.1
Seppi, K.2
Esterhammer, R.3
Kremser, C.4
Mair, K.J.5
Czermak, B.V.6
-
121
-
-
1642451932
-
Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging
-
Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, et al. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. NeuroImage 2004;21 1:229-35
-
(2004)
NeuroImage
, vol.21
, Issue.1
, pp. 229-235
-
-
Eckert, T.1
Sailer, M.2
Kaufmann, J.3
Schrader, C.4
Peschel, T.5
Bodammer, N.6
-
122
-
-
4143085873
-
Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain
-
Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C, et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004;232 3:867-73
-
(2004)
Radiology
, vol.232
, Issue.3
, pp. 867-873
-
-
Mascalchi, M.1
Lolli, F.2
Della Nave, R.3
Tessa, C.4
Petralli, R.5
Gavazzi, C.6
-
123
-
-
0025952854
-
Abnormal MRI signal in the rigid form of Huntington's disease
-
Savoiardo M, Strada L, Oliva D, Girotti F, D'Incerti L. Abnormal MRI signal in the rigid form of Huntington's disease. J Neurol Neurosurg Psychiatry 1991;54 10:888-91
-
(1991)
J Neurol Neurosurg Psychiatry
, vol.54
, Issue.10
, pp. 888-891
-
-
Savoiardo, M.1
Strada, L.2
Oliva, D.3
Girotti, F.4
D'Incerti, L.5
-
124
-
-
0027530399
-
Clinical and magnetic resonance features of the classic and akinetic-rigid variants of Huntington's disease
-
Oliva D, Carella F, Savoiardo M, Strada L, Giovannini P, Testa D, et al. Clinical and magnetic resonance features of the classic and akinetic-rigid variants of Huntington's disease. Arch Neurol 1993;50 1:17-9
-
(1993)
Arch Neurol
, vol.50
, Issue.1
, pp. 17-19
-
-
Oliva, D.1
Carella, F.2
Savoiardo, M.3
Strada, L.4
Giovannini, P.5
Testa, D.6
-
127
-
-
0021883670
-
Regional mitochondrial respiratory activity in Huntington's disease brain
-
Brennan WA Jr, Bird ED, Aprille JR. Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985;44 6:1948-50
-
(1985)
J Neurochem
, vol.44
, Issue.6
, pp. 1948-1950
-
-
Brennan Jr., W.A.1
Bird, E.D.2
Aprille, J.R.3
-
129
-
-
0029095853
-
Magnetic resonance image-directed stereotactic neurosurgery: Use of image fusion with computerized tomography to enhance spatial accuracy
-
Alexander E III, Kooy HM, van Herk M, Schwartz M, Barnes PD, Tarbell N, et al. Magnetic resonance image-directed stereotactic neurosurgery: use of image fusion with computerized tomography to enhance spatial accuracy. J Neurosurg 1995;83 2:271-6
-
(1995)
J Neurosurg
, vol.83
, Issue.2
, pp. 271-276
-
-
Alexander III, E.1
Kooy, H.M.2
Van Herk, M.3
Schwartz, M.4
Barnes, P.D.5
Tarbell, N.6
-
130
-
-
0242576248
-
Stereotactic MR imaging for planning neural transplantation: A reliable technique at 3 Tesla?
-
Donovan T, Fryer TD, Pena A, Watts C, Carpenter TA, Pickard JD. Stereotactic MR imaging for planning neural transplantation: a reliable technique at 3 Tesla? Br J Neurosurg 2003;17 5:443-9
-
(2003)
Br J Neurosurg
, vol.17
, Issue.5
, pp. 443-449
-
-
Donovan, T.1
Fryer, T.D.2
Pena, A.3
Watts, C.4
Carpenter, T.A.5
Pickard, J.D.6
-
131
-
-
0026652757
-
A comparison between magnetic resonance imaging and computed tomography for stereotactic coordinate determination
-
Kondziolka D, Dempsey PK, Lunsford LD, Kestle JR, Dolan EJ, Kanal E, et al. A comparison between magnetic resonance imaging and computed tomography for stereotactic coordinate determination. Neurosurgery 1992;30 3:402-6; discussion 406-407
-
(1992)
Neurosurgery
, vol.30
, Issue.3
, pp. 402-406
-
-
Kondziolka, D.1
Dempsey, P.K.2
Lunsford, L.D.3
Kestle, J.R.4
Dolan, E.J.5
Kanal, E.6
-
132
-
-
0343415725
-
Accuracy of magnetic resonance imaging stereotactic coordinates with the Cosman-Roberts-Wells frame
-
Carter DA, Parsai EI, Ayyangar KM. Accuracy of magnetic resonance imaging stereotactic coordinates with the Cosman-Roberts-Wells frame. Stereotact Funct Neurosurg 1999;72 1:35-46
-
(1999)
Stereotact Funct Neurosurg
, vol.72
, Issue.1
, pp. 35-46
-
-
Carter, D.A.1
Parsai, E.I.2
Ayyangar, K.M.3
-
133
-
-
0345279909
-
Activation of neurotransplants in humans
-
Bluml S, Kopyov O, Jacques S, Ross BD. Activation of neurotransplants in humans. Exp Neurol 1999;158 1:121-5
-
(1999)
Exp Neurol
, vol.158
, Issue.1
, pp. 121-125
-
-
Bluml, S.1
Kopyov, O.2
Jacques, S.3
Ross, B.D.4
-
134
-
-
0032800442
-
In vivo magnetic resonance spectroscopy of human fetal neural transplants
-
Ross BD, Hoang TQ, Bluml S, Dubowitz D, Kopyov OV, Jacques DB, et al. In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed 1999;12 4:221-36
-
(1999)
NMR Biomed
, vol.12
, Issue.4
, pp. 221-236
-
-
Ross, B.D.1
Hoang, T.Q.2
Bluml, S.3
Dubowitz, D.4
Kopyov, O.V.5
Jacques, D.B.6
-
135
-
-
16344366522
-
Positron emission tomography and single-photon emission computed tomography in central nervous system drug development
-
Brooks DJ. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development. NeuroRx 2005;2 2:226-36
-
(2005)
NeuroRx
, vol.2
, Issue.2
, pp. 226-236
-
-
Brooks, D.J.1
-
136
-
-
16544391956
-
Oligonucleotides as radiopharmaceuticals
-
Tavitian B. Oligonucleotides as radiopharmaceuticals. Ernst Schering Res Found Workshop 2005;(49):1-34
-
(2005)
Ernst Schering Res Found Workshop
, Issue.49
, pp. 1-34
-
-
Tavitian, B.1
-
137
-
-
0031824780
-
Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
-
Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ. Alpha synuclein in neurodegenerative disorders: murderer or accomplice? Nat Med 1998;4 7:755-7
-
(1998)
Nat Med
, vol.4
, Issue.7
, pp. 755-757
-
-
Mezey, E.1
Dehejia, A.2
Harta, G.3
Papp, M.I.4
Polymeropoulos, M.H.5
Brownstein, M.J.6
-
138
-
-
0033771793
-
Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
-
Goldberg MS, Lansbury PT Jr. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2000;2 7:E115-9
-
(2000)
Nat Cell Biol
, vol.2
, Issue.7
-
-
Goldberg, M.S.1
Lansbury Jr., P.T.2
-
139
-
-
84903202261
-
Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease
-
Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002;10 1:24-35
-
(2002)
Am J Geriatr Psychiatry
, vol.10
, Issue.1
, pp. 24-35
-
-
Shoghi-Jadid, K.1
Small, G.W.2
Agdeppa, E.D.3
Kepe, V.4
Ercoli, L.M.5
Siddarth, P.6
-
140
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
-
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55 3:306-19
-
(2004)
Ann Neurol
, vol.55
, Issue.3
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
Wang, Y.4
Blomqvist, G.5
Holt, D.P.6
-
141
-
-
4644283049
-
PET imaging of amyloid in Alzheimer's disease
-
Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 2004;3 9:519-27
-
(2004)
Lancet Neurol
, vol.3
, Issue.9
, pp. 519-527
-
-
Nordberg, A.1
-
142
-
-
23844456320
-
Neuroimaging in Parkinson's disease
-
Brooks DJ. Neuroimaging in Parkinson's disease. NeuroRx 2004;1 2:243-54
-
(2004)
NeuroRx
, vol.1
, Issue.2
, pp. 243-254
-
-
Brooks, D.J.1
-
143
-
-
16344381905
-
Neuroimaging and therapeutics in movement disorders
-
Eckert T, Eidelberg D. Neuroimaging and therapeutics in movement disorders. NeuroRx 2005;2 2:361-71
-
(2005)
NeuroRx
, vol.2
, Issue.2
, pp. 361-371
-
-
Eckert, T.1
Eidelberg, D.2
-
144
-
-
0031595305
-
13C-NMR of glutamate metabolism in the human brain: Initial results at 4 tesla
-
13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla. Dev Neurosci 1998;20 4-5:380-8
-
(1998)
Dev Neurosci
, vol.20
, Issue.4-5
, pp. 380-388
-
-
Gruetter, R.1
Seaquist, E.R.2
Kim, S.3
Ugurbil, K.4
-
145
-
-
0036522961
-
13C nuclear magnetic resonance spectroscopy: Elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism
-
13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 2002;22 5:1523-31
-
(2002)
J Neurosci
, vol.22
, Issue.5
, pp. 1523-1531
-
-
Lebon, V.1
Petersen, K.F.2
Cline, G.W.3
Shen, J.4
Mason, G.F.5
Dufour, S.6
-
148
-
-
7544237290
-
The fate of perfluoro-tagged metabolites of L-DOPA in mice brains
-
Dingman S, Mack D, Branch S, Thomas R, Guo C, Branch C. The fate of perfluoro-tagged metabolites of L-DOPA in mice brains. J Immunoassay Immunochem 2004;25 4:359-70
-
(2004)
J Immunoassay Immunochem
, vol.25
, Issue.4
, pp. 359-370
-
-
Dingman, S.1
Mack, D.2
Branch, S.3
Thomas, R.4
Guo, C.5
Branch, C.6
-
149
-
-
2142675181
-
Enzymatic assay for perfluoro-tagged metabolites of L-DOPA using crude lysate from E. coli transformed with pKKAADCII
-
Dingman S, Snyder-Leiby T, Mack DJ, Thomas R, Guo C. Enzymatic assay for perfluoro-tagged metabolites of L-DOPA using crude lysate from E. coli transformed with pKKAADCII. Appl Microbiol Biotechnol 2004;64 4:556-9
-
(2004)
Appl Microbiol Biotechnol
, vol.64
, Issue.4
, pp. 556-559
-
-
Dingman, S.1
Snyder-Leiby, T.2
Mack, D.J.3
Thomas, R.4
Guo, C.5
-
150
-
-
0038523950
-
Endogenous dopamine release after pharmacological challenges in Parkinson's disease
-
Piccini P, Pavese N, Brooks DJ. Endogenous dopamine release after pharmacological challenges in Parkinson's disease. Ann Neurol 2003;53 5:647-53
-
(2003)
Ann Neurol
, vol.53
, Issue.5
, pp. 647-653
-
-
Piccini, P.1
Pavese, N.2
Brooks, D.J.3
|